{
  "id": "17e3e72ba7af2f22",
  "title": "STAT+: Boehringer Ingelheim prepares schizophrenia app for FDA submission after trial results",
  "description": "Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.",
  "content": "Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/05/boehringer-schizophrenia-app-trial-data-fda-submission/?utm_campaign=rss",
  "published_at": "2025-12-05T19:47:17+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Boehringer Ingelheim prepares schizophrenia app for FDA submission after trial results",
    "description": "Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.",
    "url": "https://www.statnews.com/2025/12/05/boehringer-schizophrenia-app-trial-data-fda-submission/?utm_campaign=rss",
    "published": "2025-12-05T19:47:17+00:00",
    "source": "STAT"
  }
}